Kevin D. Bunker, Chief Operating Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 29,173 shares at $54.20 ($1.5M) on 2022-02-10, disclosed to the SEC on 2022-02-14.
Open-market sale of $1.5M ZNTL by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.15 | 2,366 | $123K | 8.1% |
| 2 | $52.15 | 2,366 | $123K | 8.1% |
| 3 | $53.19 | 3,074 | $164K | 10.7% |
| 4 | $53.19 | 3,074 | $164K | 10.7% |
| 5 | $54.20 | 3,321 | $180K | 11.8% |
| 6 | $54.20 | 3,321 |
| $180K |
| 11.8% |
| 7 | $54.96 | 1,239 | $68K | 4.4% |
| 8 | $54.96 | 1,239 | $68K | 4.4% |
| 9 | $50.16 | 1,622 | $81K | 5.3% |
| 10 | $50.16 | 1,622 | $81K | 5.3% |
| 11 | $50.29 | 2,863 | $144K | 9.4% |
| 12 | $50.29 | 2,863 | $144K | 9.4% |
| 13 | $50.75 | 203 | $10K | 0.7% |
| Total | $52.48 avg | 29,173 | $1.5M | 100% |
| Filing → |
| ZNTL | SELL | 2023-02-14 | $285K | — | Filing → |
| ZNTL | SELL | 2022-08-12 | $150K | — | Filing → |
| ZNTL | SELL | 2022-07-20 | $150K | — | Filing → |